VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
THG
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
THGThe Hanover Insurance Group, Inc.
$214.54$7.5B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksTHGFinancials

The Hanover Insurance Group, Inc. (THG) Financials

30Y historyFree accessUpdated daily

Underwriting profitability has reached an inflection point, with the combined ratio improving from a 96.7% peak in 2024Q2 to 86.1% in 2026Q1, supported by a 6.6% year-over-year revenue increase.

THG Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Revenue6.68B6.6B6.22B5.96B5.43B5.16B4.82B4.89B4.47B4.27B3.97B5.05B5.07B4.79B4.59B3.93B3.15B2.83B2.68B2.67B2.64B2.62B3.1B2.8B2.89B2.89B3.16B3.24B3.13B3.01B3.29B
Revenue Growth %6.57%6.12%4.25%9.77%5.3%7.08%-1.47%9.51%4.64%7.62%-21.45%-0.38%5.71%4.42%16.76%24.73%11.22%5.73%0.24%1.2%0.77%-15.48%10.73%-3.01%-0.02%-8.63%-2.43%3.7%3.94%-8.48%0.93%
Medical Costs & Claims4.38B3.73B4.98B5.31B4.72B4.12B3.8B3.79B3.62B3.42B3.35B3.92B3.97B3.73B3.91B3.33B2.53B2.6B2.18B1.98B1.95B2.17B2.37B2.25B2.4B2.43B2.44B2.29B2.35B2.41B2.41B
Medical Cost Ratio %65.48%56.53%80.09%89.05%86.82%79.79%78.78%77.54%80.97%80.14%84.47%77.6%78.29%77.85%85.23%84.69%80.11%91.66%81.42%74.08%73.77%82.69%76.54%80.34%83.25%84.15%77.12%70.79%75.29%80.27%73.5%
Gross Profit2.31B2.87B1.24B652.9M716.3M1.04B1.02B1.1B849.7M847.6M616M1.13B1.1B1.06B678.2M601.9M626.9M236.4M498M693.1M693.2M453.9M727.7M550.9M483.8M458M723.6M946.6M772.1M593.2M870.6M
Gross Margin %34.52%43.47%19.91%10.95%13.18%20.21%21.22%22.46%19.03%19.86%15.53%22.4%21.71%22.15%14.77%15.31%19.89%8.34%18.58%25.92%26.23%17.31%23.46%19.66%16.75%15.85%22.88%29.21%24.71%19.73%26.5%
Gross Profit Growth %-131.74%89.57%-8.85%-31.3%1.99%-6.93%29.28%0.25%37.6%-45.53%2.82%3.62%56.53%12.68%-3.99%165.19%-52.53%-28.15%-0.01%52.72%-37.63%32.09%13.87%5.63%-36.71%-23.56%22.6%30.16%-31.86%-68.73%
Operating Expenses1.39B2.02B699.9M611.8M572.3M521.4M577.6M576.4M567.2M554.7M550M691.6M722M732.5M649.5M580.3M415.8M-34.5M333.6M351.6M413.8M382.6M541M490.7M353.8M0505M0472M-2B-1.96B
OpEx / Revenue %20.74%30.68%11.26%10.26%10.53%10.11%11.99%11.79%12.7%13%13.87%13.7%14.25%15.28%14.15%14.76%13.19%-1.22%12.45%13.15%15.66%14.59%17.44%17.51%12.25%0%15.97%0%15.1%-66.68%-59.57%
Depreciation & Amortization-2.2M01.5M6.3M12.9M16.9M18.2M21.6M24.6M30.1M30.7M30.2M33.5M35M35.6M26.7M16.7M11.8M15.1M18.9M21.4M31.6M38.2M35.8M20.6M23M22.8M34.2M21.9M31.6M44.7M
Combined Ratio %86.22%87.21%91.35%99.31%97.35%89.9%90.77%89.32%93.67%93.14%98.34%91.3%92.54%93.13%99.37%99.45%93.3%90.44%93.87%87.23%89.43%97.28%93.98%97.85%95.5%84.15%93.09%70.79%90.4%13.59%13.93%
Operating Income920.8M843.8M537.8M41.1M144M521.3M444.8M522.1M282.5M292.9M66M439.4M378M329.1M28.7M21.6M211.1M270.9M164.4M341.5M279.4M71.3M186.7M60.2M130M458M218.6M946.6M300.1M2.6B2.83B
Operating Margin %13.78%12.79%8.65%0.69%2.65%10.1%9.23%10.68%6.33%6.86%1.66%8.7%7.46%6.87%0.63%0.55%6.7%9.56%6.13%12.77%10.57%2.72%6.02%2.15%4.5%15.85%6.91%29.21%9.6%86.41%86.07%
Operating Income Growth %-56.9%1208.52%-71.46%-72.38%17.2%-14.81%84.81%-3.55%343.79%-84.98%16.24%14.86%1046.69%32.87%-89.77%-22.07%64.78%-51.86%22.23%291.87%-61.81%210.13%-53.69%-71.62%109.52%-76.91%215.43%-88.45%-8.12%1.57%
EBITDA933.1M887M539.3M47.4M156.9M538.2M463M543.7M307.1M323M96.7M469.6M411.5M364.1M64.3M48.3M227.8M282.7M179.5M360.4M300.8M102.9M224.9M96M150.6M481M241.4M980.8M322M2.63B2.87B
EBITDA Margin %13.96%13.44%8.67%0.79%2.89%10.43%9.61%11.12%6.88%7.57%2.44%9.3%8.12%7.6%1.4%1.23%7.23%9.97%6.7%13.48%11.38%3.92%7.25%3.43%5.21%16.65%7.63%30.27%10.3%87.46%87.43%
Interest Expense45.5M43.2M34.1M34.1M34.1M34M37.1M37.5M45.1M45.2M51.4M60.6M65.8M65.3M61.9M55M44.3M0040.6M00000000000
Non-Operating Income-34.7M-43.2M-34.1M-34.1M-34.1M-34M-37.1M-37.5M-45.1M-45.2M-51.4M-60.6M-65.8M-65.3M-61.9M-55M-44.3M00-47.5M00000000000
Pretax Income920.8M843.8M537.8M41.1M144M521.3M444.8M522.1M282.5M292.9M66M439.4M378M329.1M28.7M21.6M211.1M270.9M164.4M341.5M279.4M71.3M186.7M60.2M130M44.7M218.6M452M300.1M277.3M257.1M
Pretax Margin %13.78%12.79%8.65%0.69%2.65%10.1%9.23%10.68%6.33%6.86%1.66%8.7%7.46%6.87%0.63%0.55%6.7%9.56%6.13%12.77%10.57%2.72%6.02%2.15%4.5%1.55%6.91%13.95%9.6%9.22%7.83%
Income Tax201.5M183.1M112.5M7.6M27.2M101.3M82.8M93.1M43.5M76.8M-1M108.6M95.7M83.4M-17.4M-9.9M57.9M83.1M79.9M113.2M87.7M-5.2M4.2M3.9M-234.8M88.2M2.7M106.9M56.1M84.7M75.2M
Effective Tax Rate %21.88%21.7%20.92%18.49%18.89%19.43%18.62%17.83%15.4%26.22%-1.52%24.72%25.32%25.34%-60.63%-45.83%27.43%30.68%48.6%33.15%31.39%-7.29%2.25%6.48%-180.62%197.32%1.24%23.65%18.69%30.54%29.25%
Net Income721.1M662.5M426M35.3M116M422.8M358.7M425.1M391M186.2M155.1M331.5M282M251M55.9M36.7M154.8M197.2M20.6M253.1M170.3M-325.2M125.3M86.9M-306.1M-3.1M199.9M295.8M201.2M209.2M181.9M
Net Margin %10.79%10.04%6.85%0.59%2.14%8.19%7.44%8.69%8.75%4.36%3.91%6.57%5.56%5.24%1.22%0.93%4.91%6.96%0.77%9.46%6.44%-12.4%4.04%3.1%-10.6%-0.11%6.32%9.13%6.44%6.96%5.54%
Net Income Growth %64.37%55.52%1106.8%-69.57%-72.56%17.87%-15.62%8.72%109.99%20.05%-53.21%17.55%12.35%349.02%52.32%-76.29%-21.5%857.28%-91.86%48.62%152.37%-359.54%44.19%128.39%-9774.19%-101.55%-32.42%47.02%-3.82%15.01%35.85%
EPS (Diluted)19.8718.5111.700.983.2111.499.4210.469.094.333.597.406.285.591.230.813.393.860.404.833.27-6.082.341.64-5.79-0.063.705.333.433.823.63
EPS Growth %65.11%58.21%1093.88%-69.47%-72.06%21.97%-9.94%15.07%109.93%20.61%-51.49%17.83%12.34%354.47%51.85%-76.11%-12.18%865%-91.72%47.71%153.78%-359.83%42.68%128.32%-9550%-101.62%-30.58%55.39%-10.21%5.23%39.08%
EPS (Basic)-18.5111.850.983.2111.799.5111.079.244.383.637.716.425.741.260.833.393.900.404.903.31-6.082.361.64-5.79-0.063.795.463.433.833.63
Diluted Shares Outstanding36.3M35.7M36.4M36.1M36.1M36.4M38.1M40.6M43M43M43.2M44.8M44.9M44.9M45.3M45.8M46.3M51.1M51.7M52.4M52.2M54M53.7M53.1M52.9M52.6M54.03M55.5M60.5M54.76M50.11M

Key Metrics

Growth RegimeExpanding
ProfitabilityStrong
Balance SheetHealthy
Cash FlowRobust
Top Statement Risk

Catastrophe-driven underwriting volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Sustained Premium Growth Through Pricing

As reported in recent financial statements, The Hanover achieved a 6.6% year-over-year revenue increase in 2026Q1, signaling that the company is successfully leveraging its independent agency distribution model to push through necessary rate adjustments in a competitive property and casualty insurance market environment.

The consistent revenue expansion suggests that the company's franchise-style agency relationships are providing significant pricing power, allowing for premium growth that outpaces broader market trends. This trajectory appears to be supported by a disciplined focus on SME accounts, which likely insulates the top line from the more aggressive price-shopping cycles seen in commoditized personal lines.

Underwriting Profitability Reaching Inflection Point

Based on the provided quarterly data, the combined ratio improved to 86.1% in 2026Q1, reflecting a notable recovery from the 96.7% peak observed in 2024Q2 and indicating that the company's underwriting discipline is effectively translating into superior margin expansion during the current hard market cycle.

The sharp reduction in the combined ratio suggests that management's efforts to prune underperforming geographic territories and lines of business are yielding tangible results. Investors should monitor whether this margin improvement is sustainable or if it remains overly sensitive to the volatility of secondary catastrophe perils.

Recovery From 2024 Catastrophe Volatility

According to historical income statement data, the company navigated a challenging 2024Q2 period where the combined ratio spiked to 96.7%, but has since demonstrated a clear recovery trend, with underwriting performance stabilizing significantly as the firm successfully adjusted its risk appetite and pricing strategies.

This period serves as a critical inflection point that highlights the company's sensitivity to weather-related loss volatility. The subsequent improvement in operating income suggests that the firm has successfully recalibrated its exposure, though the reliance on favorable weather patterns warrants continued scrutiny of its long-term loss-cost management.

Reserve Adequacy and Litigation Tailwinds

While the current underwriting margins appear robust, the potential for social inflation to impact long-tail liability reserves remains a significant analytical concern, as indicated by the historical fluctuations in loss ratios that may mask underlying development trends within the company's commercial lines segment.

The reliance on prior-year reserve development to bolster current earnings requires careful investigation, as it may obscure the true attritional loss ratio. If litigation trends in the Northeast and Midwest continue to accelerate, the company may face future reserve strengthening requirements that could pressure future profitability.

THG — Frequently Asked Questions

Quick answers to the most common questions about buying THG stock.

What was The Hanover Insurance Group, Inc.'s (THG) revenue in 2025?

For fiscal year 2025, The Hanover Insurance Group, Inc. (THG) reported total revenue of $6.60B. This represents a 100.8% increase compared to $3.29B in 1996.

Is The Hanover Insurance Group, Inc. (THG) profitable?

The Hanover Insurance Group, Inc. (THG) is profitable, generating $662.5M in net income for the fiscal year ending 2025 with a net profit margin of 10.0%.

What is The Hanover Insurance Group, Inc.'s operating profit margin?

The Hanover Insurance Group, Inc. (THG) reported an operating income of $843.8M, resulting in an operating profit margin of 12.8%. This margin reflects the operational efficiency of the business before interest and taxes.

What is The Hanover Insurance Group, Inc.'s gross profit and gross margin?

The Hanover Insurance Group, Inc. (THG) generated $2.87B in gross profit for the year, representing a gross profit margin of 43.5%. This demonstrates the company's core pricing power and production efficiency.